Results of 15 Gy HDR-BT boost plus EBRT in intermediate-risk prostate cancer: Analysis of over 500 patients. - Martell, K.; Mendez, L.C.; Chung, H.T.; Tseng, C.L.; Alayed, Y.; Cheung, P.; Liu, S.; Vesprini, D.; Chu, W.; Wronski, M.; Szumacher, E.; Ravi, A.; et al. (Radiotherapy & Oncology, 2019)